DEGRO practical guidelines: radiotherapy of breast cancer I
Open Access
- 5 September 2013
- journal article
- practice guideline
- Published by Springer Science and Business Media LLC in Strahlentherapie und Onkologie
- Vol. 189 (10), 825-833
- https://doi.org/10.1007/s00066-013-0437-8
Abstract
Background and purpose The aim of the present paper is to update the practical guidelines for postoperative adjuvant radiotherapy of breast cancer published in 2007 by the breast cancer expert panel of the German Society for Radiooncology (Deutsche Gesellschaft für Radioonkologie, DEGRO). The present recommendations are based on a revision of the German interdisciplinary S-3 guidelines published in July 2012. Methods A comprehensive survey of the literature concerning radiotherapy following breast conserving therapy (BCT) was performed using the search terms “breast cancer”, “radiotherapy”, and “breast conserving therapy”. Data from lately published meta-analyses, recent randomized trials, and guidelines of international breast cancer societies, yielding new aspects compared to 2007, provided the basis for defining recommendations according to the criteria of evidence-based medicine. In addition to the more general statements of the DKG (Deutsche Krebsgesellschaft), this paper addresses indications, target definition, dosage, and technique of radiotherapy of the breast after conservative surgery for invasive breast cancer. Results Among numerous reports on the effect of radiotherapy during BCT published since the last recommendations, the recent EBCTCG report builds the largest meta-analysis so far available. In a 15 year follow-up on 10,801 patients, whole breast irradiation (WBI) halves the average annual rate of disease recurrence (RR 0.52, 0.48–0.56) and reduces the annual breast cancer death rate by about one sixth (RR 0.82, 0.75–0.90), with a similar proportional, but different absolute benefit in prognostic subgroups (EBCTCG 2011). Furthermore, there is growing evidence that risk-adapted dose augmentation strategies to the tumor bed as well as the implementation of high precision RT techniques (e.g., intraoperative radiotherapy) contribute substantially to a further reduction of local relapse rates. A main focus of ongoing research lies in partial breast irradiation strategies as well as WBI hypofractionation schedules. The potential of both in replacing normofractionated WBI has not yet been finally clarified. Conclusion After breast conserving surgery, no subgroup even in low risk patients has yet been identified for whom radiotherapy can be safely omitted without compromising local control and, hence, cancer-specific survival. In most patients, this translates into an overall survival benefit.Keywords
This publication has 89 references indexed in Scilit:
- Accelerated partial breast irradiation with intraoperative electrons: Using GEC–ESTRO recommendations as guidance for patient selectionRadiotherapy and Oncology, 2013
- How Do the ASTRO Consensus Statement Guidelines for the Application of Accelerated Partial Breast Irradiation Fit Intraoperative Radiotherapy? A Retrospective Analysis of Patients Treated at the European Institute of OncologyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Effect of Occult Metastases on Survival in Node-Negative Breast CancerThe New England Journal of Medicine, 2011
- Development and Validation of a Heart Atlas to Study Cardiac Exposure to Radiation Following Treatment for Breast CancerInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Accelerated Partial Breast Irradiation (APBI): A review of available techniquesRadiation Oncology, 2010
- Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electronsBreast Cancer Research and Treatment, 2010
- Evaluation of Multiple Breathing States Using a Multiple Instance Geometry Approximation (MIGA) in Inverse-Planned Optimization for Locoregional Breast TreatmentInternational Journal of Radiation Oncology*Biology*Physics, 2008
- The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialThe Lancet Oncology, 2008
- The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialThe Lancet, 2008